NVST · Envista Holdings Corp · Executive Compensation
$23.62
-0.41 (-1.71%)
At close · Nov 17
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$3.85B
Shares
160.34M
Volume · Nov 17
394.18K
Avg daily vol (3M)
2.88M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Paul Keel | President & CEO | $10,559,567 |
| Eric Hammes | Chief Financial Officer | $2,645,970 |
| Mark Nance | SVP and General Counsel | $2,645,186 |
| Veronica Acurio | President, Orthodontics | $2,173,104 |
| Robert Befidi | President, Diagnostics | $1,936,267 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Paul Keel | President & CEO, from May 1, 2024 | $24,236,357 |
| Eric Hammes | Chief Financial Officer, from August 1, 2024 | $3,202,920 |
| Mark Nance | SVP and General Counsel | $3,103,878 |
| Robert Befidi | President, Diagnostics | $2,314,339 |
| Stephen Keller | Principal Financial Officer, until August 1, 2024 | $1,397,193 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Amir Aghdaei | President & CEO, until May 1, 2024 | $7,059,325 |
| Howard Yu | Senior Vice President and CFO, until September 22, 2023 | $2,238,827 |
| Eric Conley | President, Orthodontics | $2,117,261 |
| Jean-Claude Kyrillos | SVP and President, Diagnostics and Digital Solutions, until June 30, 2023 | $1,849,192 |
| Patrik Eriksson | SVP and President of Nobel Biocare, until December 31, 2023 | $1,601,606 |
| Mark Nance | SVP and General Counsel | $1,543,140 |
| Stephen Keller | Principal Financial Officer, until August 1, 2024 | $703,927 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Amir Aghdaei | President & CEO, until May 1, 2024 | $8,523,732 |
| Howard Yu | Senior Vice President and CFO, until September 22, 2023 | $2,342,263 |
| Patrik Eriksson | SVP and President of Nobel Biocare, until December 31, 2023 | $1,684,768 |
| Jean-Claude Kyrillos | SVP and President, Diagnostics and Digital Solutions, until June 30, 2023 | $1,664,164 |
| Mark Nance | SVP and General Counsel | $1,654,035 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Amir Aghdaei | President & CEO | $9,199,748 |
| Jean-Claude Kyrillos | SVP and President, Diagnostics and Digital Solutions, until June 30, 2023 | $3,855,308 |
| Howard Yu | Senior Vice President and CFO, until September 22, 2023 | $2,227,730 |
| Patrik Eriksson | SVP and President of Nobel Biocare, until December 31, 2023 | $2,019,011 |
| Mark Nance | SVP and General Counsel | $1,795,502 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Amir Aghdaei | President & CEO | $7,370,894 |
| Howard Yu | Senior Vice President and CFO | $1,933,652 |
| Patrik Eriksson | SVP and President of Nobel Biocare | $1,796,915 |
| Mark Nance | SVP and General Counsel | $1,428,725 |
| Jean-Claude Kyrillos | SVP and President, Diagnostics and Digital Solutions | $1,403,274 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Amir Aghdaei | President & CEO | $7,582,512 |
| Hans Geiselhöringer | Senior Vice President | $2,374,203 |
| Patrik Eriksson | SVP and President of Nobel Biocare | $2,331,345 |
| Curt Bludworth | Senior Vice President & CHRO | $2,032,574 |
| Howard Yu | Senior Vice President and CFO | $2,003,601 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Amir Aghdaei | President & CEO | $6,599,157 |
| Hans Geiselhöringer | Senior Vice President | $2,137,503 |
| Howard Yu | Senior Vice President and CFO | $1,921,739 |
| Curt Bludworth | Senior Vice President & CHRO | $1,453,824 |
| Patrik Eriksson | SVP and President of Nobel Biocare | $1,453,001 |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| Amir Aghdaei | President & CEO | $3,510,298 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Scott Huennekens | Lead Independent Director | Appointed | 2026-08-19 |
| Paul Keel | Chair of the Board | Appointed | 2026-08-19 |
| Coree Thomas | Vice President and Chief Accounting Officer | Appointed | 2026-06-03 |
|
Faez Kaabi
“Mr. Kaabi’s resignation is in connection with his retirement and not the result of any disagreement with the Company regarding financial disclosures, accounting matters, or other policies or practices.”
|
Chief Accounting Officer and principal accounting officer | Resigned | 2026-06-03 |
| Barbara B. Hulit | Board of Directors | Resigned | 2025-09-17 |
| J. Andrew Pierce | Board of Directors | Appointed | 2025-07-16 |
| Veronica Acurio | President, Orthodontics | Appointed | 2024-07-15 |
| Stefan Nilsson | President, Nobel Biocare | Appointed | 2024-07-15 |
| Eric Hammes | Senior Vice President and Chief Financial Officer | Appointed | 2024-07-15 |
| Eric Conley | SVP and President, Orthodontics | Resigned | 2024-05-30 |
| Amir Aghdaei | director of the Board | Resigned | 2024-04-15 |
| Paul Keel | member of the Board of Directors | Appointed | 2024-04-15 |
| Paul Keel | President and Chief Executive Officer | Appointed | 2024-04-15 |
| Patrik Eriksson | SVP and President, Nobel Biocare | Terminated | 2023-12-14 |
| Jean-Claude Kyrillos | SVP and President, Diagnostics and Digital Solutions | Terminated | 2023-06-30 |
| Jean-Claude Kyrillos | SVP and President, Diagnostics and Digital Solutions | Terminated | 2023-04-14 |
Leadership
- Paul Keel Chairman, Board Member
- Andrew Chen CIO
- Mark Nance General Counsel
- Coree Thomas Chief Accounting Officer
- Howard H. Yu Chief Accounting Officer
- Christine Tsingos Board Member
- Daniel Raskas Board Member
- Gayle Sheppard Board Member
- J. Andrew Pierce Board Member
- Kieran T. Gallahue Board Member
- Scott Huennekens Board Member
- Vivek Jain Board Member
- Wendy Carruthers Board Member
Key facts
CIK
1757073
CUSIP
29415F104
13F (30d)
395 filings
375 filers
Visit website
Investor relations